Concepedia

Jörg Linder

JL

Statistics

Publications

3

Citations

37

H-Index

3

Active since

2023

Affiliations

Janssen (Germany)(Current)

Johnson & Johnson (United States)

Jörg Linder is an author at Janssen (Germany) specializing in adherence, clinical trials, and combination therapy.

Publications per year

2023–2024

3

Publications

3

Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)

Hilary M. DuBrock, Hayley D. Germack, Marjolaine Gauthier‐Loiselle et al. · PharmacoEconomics - Open · 2023 · 13 citations · Full text

, , +17

Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes

Carly J. Paoli, Jörg Linder, Khushboo Gurjar et al. · Journal of health economics and outcomes research · 2024 · 12 citations · Full text

, , +15

The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey

Mark Small, Alex Bennett, Jörg Linder · Therapeutic Advances in Respiratory Disease · 2024 · 12 citations · Full text

, , +11

1–3 of 3